Large-Molecule Injectable Drugs Market: Increase in Investments in R&D Activities Fuels the Global Market
Large molecules (biologics), also called as biopharmaceuticals, is a class of drugs that are based on proteins which have a therapeutic effect. Some of the key therapeutic proteins which are widely used as biologic drugs are victoza, rebif, levemir, humalog, Lantus, enbrel, novolog, and epogen. Biologics consist of more than 1300 amino acids. These can be as heavy as 150kDa. These are advanced versions of endogenous human proteins. These large molecules bind to a specific cell receptors that are associated...
View full press release